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Abstract
Polycomb Repressor Complexes (PRCs) are important regulators of embryogenesis. In embryonic
stem (ES) cells many genes that regulate subsequent stages in development are enriched at their
promoters for PRC1, PRC2 and Ser 5-phosphorylated RNA Polymerase II (RNAP), and contain
domains of ‘bivalent’ chromatin (enriched for H3K4me3; histone H3 di- or trimethylated at Lys 4
and H3K27me3; histone H3 trimethylated at Lys 27). Loss of individual PRC components in ES
cells can lead to gene de-repression and to unscheduled differentiation. Here we show that Jarid2
is a novel subunit of PRC2 that is required for the co-recruitment of PRC1 and RNAP to genes
that regulate development in ES cells. Jarid2-deficient ES cells showed reduced H3K4me2/me3
and H3K27me3 marking and PRC1/PRC2 recruitment, and did not efficiently establish Ser 5-
phosporylated RNAP at target genes. ES cells lacking Jarid2, in contrast to previously
characterized PRC1 and PRC2 mutants, did not inappropriately express PRC2 target genes.
Instead, they show a severely compromised capacity for successful differentiation towards neural
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or mesodermal fates and failed to correctly initiate lineage-specific gene expression in vitro.
Collectively, these data indicate that transcriptional priming of bivalent genes in pluripotent ES
cells is Jarid2-dependent, and suggests that priming is critical for subsequent multi-lineage
differentiation.
In undifferentiated ES cells, many genes that encode transcription factors that are required
for subsequent stages of development are enriched with histones modified simultaneously
for active transcription (H3K4me2/me3) and PRC2-mediated repression (H3K27me3)1-4. It
has been suggested that this chromatin profile—often referred to as bivalent—serves to
prime undifferentiated cells to respond rapidly to lineage induction5-7. Although there is a
paucity of experimental data to validate or refute this idea, reports have shown evidence of
transcriptional priming in ES cells, as well as other cell types8-10. Importantly, RNAP is
enriched at many PRC1/PRC2 target genes in mouse ES cells in a Ser 5-phosphorylated
form that is ‘poised’ but inhibited (at least in part) by PRC1-mediated H2Aub1, and fails to
efficiently elongate or produce mature transcripts8. Experimental removal of PRC1 or PRC2
in ES cells leads to gene derepression in vitro2-4,8,11-13, and early embryonic lethality in
vivo14-17. Although these data show that bivalent genes are poised for expression in ES
cells, they do not address whether transcriptional priming is central to the core biological
properties of ES cells to self-renew and execute multi-lineage differentiation.
To identify PRC2-interacting proteins in mouse ES cells we used mass spectroscopy, and
generated an ES cell line that stably expressed amino-terminal 2×Flag-tagged Eed isoform 3
as bait. Western blot analysis confirmed that expression of 2×Flag–Eed in these cells was
moderate, and did not substantially elevate overall Eed levels (Supplementary Information,
Fig. S1a). Flag antibodies immunoprecipitated proteins with the expected sizes of PRC2
core components from 2×Flag–Eed-transfected, but not parental, ES cells (Fig. 1a). Mass
spectrometry of the immunoprecipitated material confirmed the presence of PRC2 core
components, and in addition, showed that Jarid2 and Pcl2 were present in abundance (Fig.
1a).
To verify that Jarid2 associates with the PRC2 complex in vivo, we generated 2×Flag–Jarid2
ES cells. Immunoprecipitation with Flag antibodies from 2×Flag–Jarid2 ES cells showed
bands, not seen in samples from parental ES cells, with the expected sizes of the PRC2 core
members Eed, Ezh2 and Suz12, in addition to 2×Flag–Jarid2 (Fig. 1b). Mass spectrometry
of the immunoprecipitated material confirmed the presence of Suz12, Ezh2 and Eed, as well
as Aebp2 (Fig. 1b); a zinc-finger protein that has been reported to enhance H3K27
methylation activity by PRC2 (ref. 18). Ezh1 and Pcl2 were readily co-immunoprecipitated
with Eed (Fig. 1a), but not with Jarid2 (Fig. 1b), suggesting that Jarid2 and Ezh1/Pcl2 reside
in distinct PCR2 sub-complexes. To confirm that Jarid2 interacts with Eed in vivo, we
immunoprecipitated endogenous Eed from wild-type ES cells. Western blotting
demonstrated that Eed co-immunoprecipitated Jarid2 as well as Ezh2 and Suz12 (Fig. 1c).
Interaction between Jarid2 and PRC2 components persisted in the presence of ethidium
bromide, suggesting that it was direct and not mediated by DNA. The reverse
immunoprecipitation experiment in 2×Flag–Jarid2 ES cells confirmed that 2×Flag–Jarid2
interacts with Ezh2, Suz12 and Eed (particularly isoform 3) (Fig. 1d). These data indicate
that Jarid2 is a component of PRC2 in ES cells.
The genomic targets of Jarid2 in mouse ES cells were identified by chromatin
immunoprecipitation followed by genomic tiling arrays (ChIP-chip). These contained
regions of 200 kilobases (kb) to 2 megabases (Mb) surrounding 120 selected loci, and a
contiguous section of mouse chromosome 17 (approximately 3% of the unique sequence
content of the mouse genome covering 1,098 annotated genes19). Flag-ChIP showed
localization of Jarid2 to 626 sites (false discovery rate 5%), of which 109 mapped within 1
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kb upstream of transcription start sites (TSS) at promoter regions (< 1 kb upstream of TSS).
This represents a 12-fold preference of Jarid2 for 5′ upstream sequences, compared with
other regions of the genome (P = 2.2 × 10−16, chi-squared test). More than 90% of
promoters bound by Jarid2 were also associated with PRC2 components (Eed/Suz12) and/or
enriched in H3K27me3, based on comparison with published tiling array data2 covering 97
of these promoters (Fig. 1e). Binding of histone H3K27me3 or H3K4me2 had been reported
for 81 of our Jarid2 targets20, and 70 of these were marked by both H3K27me3 and
H3K4me2. This represents a striking preference of Jarid2 for bivalent promoters (P = 2.31 ×
10−62, chi-squared test; Fig. 1f). Jarid2 also showed a significant preference for promoters
with high CpG density and was underrepresented at promoters with low CpG content (P =
6.15 × 10−6, chi-squared test; data not shown). Flag-ChIP of 2×Flag-Jarid2 followed by
quantitative PCR (qPCR) confirmed binding of Jarid2 to each of seven bivalent promoters
tested (Supplementary Information, Fig. S1b). For three bivalent loci (Dach1, Sox7 and
Nkx2-2) we profiled binding over a larger region around the TSS and found that Jarid2
recapitulated the profile of H3K4me2 enrichment (Supplementary Information, Fig. S1c).
Thus, genome-scale analysis of Jarid2 targets shows a highly significant overlap between
Jarid2 and PRC2 at the promoters of bivalent genes in mouse ES cells.
To probe the effect of Jarid2 on histone methylation levels, we transfected HEK293T cells
with Jarid2 (Supplementary Information, Fig. S1d) and found H3K4me2/3 levels unchanged
(Supplementary Information, Fig. S1e). As a control, overexpression of the H3K4-specific
demethylase JARID1A (RBP2; Supplementary Information, Fig. S1d) resulted in
significantly reduced methylation levels (Supplementary Information, Fig. S1e). H3K9
methylation was unaffected by both Jarid2 and RBP2 overexpression and Jarid2 did not
measurably affect H3K27me3, H3K36me2 and H4K20me2/me3 levels (Supplementary
Information, Fig. S1e), suggesting that Jarid2 is not catalytically active in these assays.
Jarid2 heterozygous ES cells were obtained through the knockout mouse project (KOMP),
and we generated homozygous mutant Jarid2 cells by targeting the second allele
(Supplementary Information, Fig. S2a). Long-range PCR confirmed that heterozygous
(A08) and homozygous Jarid2-knockout lines (E4 and E8) contained one- or two-targeted
Jarid2 alleles, respectively (Supplementary Information, Figures S2a, S2b). Western blotting
showed that Jarid2 protein was reduced in Jarid2+/− and undetectable in Jarid2−/− samples
relative to wild-type (Fig. 2a). Jarid2−/− cells retained normal levels of Oct4 protein (Fig.
2a), Oct4, Sox2 and Nanog transcripts, and expressed similar levels of PRC2 components
(Supplementary Information, Fig. S2c, d). Jarid2−/− ES cell colonies showed similar levels
of alkaline phosphatase activity as controls (Supplementary Information, Fig. S2e), although
Jarid2-deficient and -null lines had a more dispersed appearance (Fig. 2b). Jarid2-deficient
ES cells grew faster (Fig. 2c), and when plated at low density generated more colonies than
wild-type (Fig. 2d). Assessment of cell-cycle phases using propidium iodide labelling
(Supplementary Information, Fig. S2f) showed that Jarid2−/−, Jarid2+/− and wild-type cells
all had broadly similar profiles; immunofluorescence labelling confirmed that most cells
within these cultures remained undifferentiated and expressed Oct4 (> 95%, Supplementary
Information, Fig. S2g) and SSEA1 (> 99%, data not shown). These results show that Jarid2-
deficient ES cells retain pluripotency markers and have enhanced growth and cloning
efficiencies without marked disturbance in cell-cycle progression.
ES cells lacking individual PRC2 components inappropriately express PRC2 target genes
and are prone to unscheduled differentiation2-4,11,13,21. To investigate whether Jarid2 has a
similar repressive function we examined transcript levels in wild-type, Jarid2+/− and
Jarid2−/− ES cells, using reverse transcription quantitative PCR (RT-qPCR) and Eed−/− ES
cells as controls. In contrast to Eed−/− ES cells (Fig. 2e; blue), Jarid2-deficiency did not
result in derepression of most of the PRC2 target genes tested (Fig. 2e), including those
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bound by Jarid2 (Supplementary Information, Fig. S1b). Jarid2-deficient cells tended to
express even lower levels of most of these genes than parental cells. These results suggest
that Jarid2, unlike the PRC2 components Eed, Suz12 and Ezh2, is not essential for PRC2-
mediated gene repression in ES cells.
To determine whether Jarid2 is important for the recruitment of PRC1 and PRC2
components to target genes in ES cells we performed ChIP analysis. Jarid2-deficient ES
cells showed reduced binding of Ezh2 and Suz12 to the promoters of each of seven PRC2
target genes tested (Mash1, Wnt1, Pax3, Nkx2-2, Sox7, Dach1 and Sox1) (Fig. 3a), and at
the Nkx2-2 locus (Fig. 3b; Supplementary Information, Fig. S3); an extensively
characterized bivalent domain8. H3K27me3, H3K4me2 and H3K4me3 levels at each of
these loci were diminished in Jarid2-deficient ES cells, compared with wild-type (Fig. 3c, d;
Supplementary Information, Fig. S3), although levels remained above the background
signal. The binding of PRC1 components Ring1B and Mel18 to target promoters was also
reduced in Jarid2−/− ES cells (Fig. 4a, left) as well as across the Nkx2-2 locus (Fig. 4a right;
Supplementary Information, Fig. S3). Hence, PRC1 is not efficiently recruited to PRC2
target genes in the absence of Jarid2.
As PRC1 is thought to mediate the silencing of many PRC2 target genes, it was surprising
that PRC2 targets are not de-repressed in ES cells lacking Jarid2. Lack of de-repression
could not be ascribed to increased DNA methylation, as bisulphite sequencing of five PRC2
target genes (Sox30, Pax5, Hoxa10, Irx3 and Math1) showed no appreciable differences
between Jarid2−/− and wild-type ES cells (Supplementary Information, Fig. S4). We
therefore examined alternative mechanisms to explain the continued transcriptional
inactivity of PRC2 target genes in Jarid2-deficient ES cells. H2Aub1, the histone
modification catalysed by the PRC1 complex was reduced in Jarid2−/− cells (Supplementary
Information, Fig. S5a), although this was less striking than the decrease of Ring1B and
Mel18.
In wild-type ES cells RNAP is engaged at PRC2 target gene promoters8,9, but shows an
unusual set of post-translational modifications22 in which high levels of phosphorylated Ser
5 are present, but detection of phosphorylated Ser 2 and reactivity with 8WG16 (an antibody
that preferentially recognizes non-phosphorylated Ser2 residues of RNAP) is low.
Consistent with this, phosphorylated Ser 5 RNAP was abundant at the promoters of actively
expressed genes (such as Hprt, Oct4 and Ccnd1) and PRC2-target genes in wild-type ES
cells (Fig. 4b, black bars, upper panel). In striking contrast, only low levels of
phosphorylated Ser 5 RNAP were detected in Jarid2−/− ES cells at six of seven PRC2 target
genes and across the Nkx2-2 locus (Fig. 4b; Supplementary Information, Fig. S5a). As
expected, hypophosphorylated RNAP was detected at active genes (Hprt, Oct and Ccnd1) in
both wild-type and Jarid2-deficient ES cells (Fig. 4b, lower panels), but was not detected at
silent (Gata1 and Myf5) or bivalent loci (Mash1, Wnt1, Pax3, Nkx2-2, Sox7, Dach1 and
Msx1), regardless of Jarid2 status. TATA-binding protein (TBP), a transcription factor
known to bind polycomb-repressed promoters in Drosophila cells23, was detected at the
promoters of expressed and bivalent genes in Jarid2-deficient and wild-type ES cells
(Supplementary Information, Fig. S5b). These data reveal a defect in recruiting
phosphorylated Ser 5 RNAP to PRC2 target genes in Jarid2-deficient ES cells, and provide
evidence that Jarid2 is critical for the transcriptional priming of these genes in ES cells.
Jarid2 expression is dependent on the triad of transcription factors Oct4, Sox2 and Nanog,
and is downregulated upon ES cell differentiation24-26. Consistently with this, Jarid2 was
downregulated when wild-type ES cells were induced to differentiate into neuronal cells or
mesoderm (Supplementary Information, Fig. S6). In contrast to wild-type ES cells, Jarid2−/−
ES cells were unable to differentiate efficiently in response to withdrawal of leukaemia
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inhibitory factor (LIF), neural induction (Fig. 5a) or mesoderm induction (Fig. 5b).
Differentiation of Jarid2−/− ES cells towards Flk1-expressing hemangioblasts27 was also
severely compromised (Fig. 5b, lower panel). Jarid2-deficient cells formed only rudimentary
embryoid bodies, which, in contrast to wild-type embryoid bodies, continued to express
Oct4 and Nanog protein and failed to express Nestin (Fig. 5c). Jarid2+/− cells showed an
intermediate phenotype, with a partial downregulation of Oct4 and Nanog and delayed
induction of Nestin (Fig. 5c). Similarly, Dach1, Irx3, Wnt1, Mash1 and Pax3 transcripts
were upregulated on neural induction of wild-type (Fig. 5d, black bars), but not in Jarid2−/−
ES cells (Fig. 5d, white bars). These data show that Jarid2 is important for the successful
execution of multiple differentiation pathways.
Jarid2 is essential for mouse development28,29, and is a recognized component of
pluripotency networks24-26. Recently, Jarid2 was shown to associate with the PRC2
complex in ES cells and to occupy many polycomb targets genome-wide30-33. These reports
have suggested that Jarid2 modulates H3K27me3 levels in ES cells through PRC2
recruitment, but have offered contradictory views on whether Jarid2 inhibits30,31 or
stimulates32,33 PRC2 histone methyltransferase activity. Our data show that in the absence
of Jarid2, PRC2-target genes in ES cells show modest reductions in both H3K27me3 and
H3K4me2/3 levels, a corresponding reduction in PRC1 recruitment and rather mild effects
on downstream H2Aub1. Perhaps the most surprising observation is that ES cells lacking
Jarid2 failed to efficiently establish ‘initiating’ Ser 5 RNAP at PRC2 target genes. In wild-
type ES cells, where PRC1 and Ser 5 RNAP are bound at many PRC2 targets2,8, withdrawal
of Eed, Suz12, Ezh2 or Ring1A/B results in the de-repression of target genes2-4,8,11-13. In
Jarid2-deficient ES cells a functionally ‘poised’ or ‘primed’ state is clearly not established, a
point that is reinforced by the finding that expression of PRC2 target genes in Jarid2-
depleted ES cells is actually lower than the basal transcript levels detected in wild-type ES
cells. In addition, we have shown that Jarid2-deficient ES cells are unable to efficiently
differentiate to mesoderm or neural lineages in vitro but exhibit enhanced proliferation when
maintained in conditions that support the undifferentiated state. The compromised
differentiation of Jarid2-deficient ES cells described here is similar to recently reported
deficits in ‘cell fate transition’ and lineage induction reported for Jarid2 knockout31 or
Jarid2-shRNA-treated (knockdown) ES cells33. Our data, showing that in the absence of
Jarid2 important development regulator genes in ES cells are not efficiently primed, may
provide an explanation for the failure of these cells to respond in a timely and appropriate
way to developmental cues. The requirement for Jarid2 during ES cell differentiation is
particularly intriguing as ES cells normally downregulate Jarid2 expression soon after the
onset of differentiation. This suggests that Jarid2 has a critical role in undifferentiated ES
cells either in preserving their multi-lineage potential status or in mediating the successful
switching of ES cells from a proliferative to a differentiating state. The fact that Jarid2 is
also required to efficiently establish a poised RNAP configuration at PRC2 targets in ES
cells provides further evidence that transcriptional priming of key regulators is important for
pluripotent function.
METHODS
Generation of Flag-fusion-expressing cell lines
Jarid2 and Eed isoform 3 cDNA were cloned from OS25 ES cell mRNA using
oligonucleotides: 5′-GGATCCATGTCCGAGAGGGAAGTGTCG-3′ 5′-
GAATTCTTATCGAAGTCGATCCCATCGC-3′ for Eed and 5′-
TGATCAATGAGCAAGGAAAGACCCAAG-3′ and 5′-
TCTAGATCATGAGGATGGGAGCCG-3′ for Jarid2. cDNA was cloned into
2×FlagpCDNA3 through BamHI/EcoRI (Eed) and BamHI/XbaI (Jarid2) restriction sites.
cDNA from 2×Flag-Eed and 2×Flag-Jarid2 cells was excised and cloned into the chicken β-
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actin promoter-driven expression vector pCBA36 and used to stably transfect E14 (2× Flag-
Jarid2) and Ezfl (2×Flag-Eed) murine ES cell lines using Lipofectamine 2000 (Invitrogen)
and G418 selection (300 μg ml−1 for 6 days). ES cells were cultured on gelatin coated
dishes in the presence of LIF at 37 °C and 5% CO2. Eed expression by 2×Flag-Eed ES cells
is shown in Supplementary Information, Figure S1a. Jarid2 expression by 2×Flag-Jarid2 ES
cells was modestly increased over endogenous levels (~20%, data not shown).
Immunoprecipitation and Mass Spectrometric analysis
Immunoprecipitation, silver staining and mass spectrometric analysis were carried out as
described37 with the following antibodies: mouse anti-Eed (A. Otte, University of
Amsterdam, NL), mouse anti-Flag (Sigma) and mouse IgG (Santa Cruz Biotechnology).
Jarid2 and RBP2 expression in HEK293T cells
HEK293T cells were transiently transfected with pCDNA3 (Invitrogen), pCDNA3
containing 2×Flag-Jarid2 (as above) or human RBP2 cDNA, using calcium phosphate.
Western blot analysis
Western blots were carried out using the following antibodies: rabbit antisera to Jarid2
(1:1,000) (Abcam or Y. Lee, University Wisconsin, USA), histone H3 (1:30,000; Abcam),
H3K4me3 (1:1,000; Abcam), H3K4me2 (1:1,000; Millipore), H3K36me3 (1:1,000;
Abcam), H3K9me3 (1:1,000; Millipore), H3K9me2 (1:1,000; Diagenode), H3K36me2
(1:1,000; Millipore), H3K27me3 (1:1,000; Millipore), H4K20me3 (1:1,000; Abcam),
H4K20me2 (1:1,000; Millipore), Suz12 (1:1,000; Diagenode), Ezh2 (1:1,000; Millipore)
and Nanog (1:200; Cosmo Bio Co.); mouse antibodies to Eed (1:2,000; A. Otte), Nestin
(1:500; BD Biosciences) and Flag (1:1000; Sigma) and goat antibodies to LaminB
(1:30,000; Santa Cruz Biotechnology) and Oct4 (1:5,000; Santa Cruz Biotechnology).
Secondary species-specific antibodies were anti-goat-HRP (Santa Cruz), anti-mouse-HRP
(GE Healthcare) and anti-rabbit-HRP (GE Healthcare). For detection Amersham ECL Plus
(GE Healthcare) was used.
2×Flag-Jarid2 ChIP-on-chip analysis
Cells were fixed in PBS in 1% paraformaldehyde (15 min, 25 °C), quenched with 125mM
glycine and lysed in a solution containing 5mM PIPES at pH 8.0, 85mM KCl and 0.5%
NP-40 for 20 min at 4 °C. After spinning, nuclei were resuspended in a solution containing
1% SDS, 10mM EDTA at pH 8.0 and 50mM Tris at pH 8.1, diluted 1:1 in radio
immunoprecipitation assay (RIPA) buffer, and sonicated until DNA fragment size was 0.2-2
kb. Flag M2 antibody (25 μg; Sigma) and Protein-G-Dynabeads (Invitrogen) were used.
Elution was performed with 250 μl of RIPA buffer containing 0.05 mg of 3×Flag peptide
(Sigma). Reverse crosslinked DNA was purified using QIAquick spin columns and eluted in
60μl Buffer EB (Qiagen). ChIP samples were amplified according to manufacturer’s
instructions (Nimblegen) for hybridization to custom tiling arrays with 380,000 features at
100 bp resolution, and results were analysed using Tilemap software. The comparison with
the Mohn et al. data set20 was based on chromosomal coordinates available at (http://
www.fmi.ch/groups/schubeler.d/web/supplements/Mohn_2008_promoters.txt) after
conversion from mm8 (NCBI build 36) to mm5 (NCBI build 33) by using the UCSC
LiftOver tool.
Histone modifications, polycomb proteins and RNAP ChIP analysis
ChIP experiments for methylated histones were performed as described above with the
following modifications. For each immunoprecipitation, 100 μg of chromatin was incubated
with 10 μg of one of the following antibodies: anti-H3 (Abcam), anti-H3K4me2 (Millipore),
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anti-H3K4me3 (Abcam), anti-H3K27me3 (Millipore) and Protein A-Dynabeads
(Invitrogen). ChIP experiments of Ezh2 and Suz12 were performed as above, but the cells
were fixed in medium with 1% paraformaldehyde for 10 min and using 10 μg of anti-Ezh2
(Diagenode) and anti-Suz12 (Cell signaling), respectively. ChIP experiments for H2Aub1,
Mel18, Ring1B and Tbp were performed using conditions previously described8 and anti-
ubiquityl-Histone H2A (Millipore), anti-Mel18 (Santa Cruz), anti-Ring1B (MBL) or anti-
TBP (Santa Cruz), respectively, and ProteinA/G-Dynabeads (Invitrogen). ChIP experiments
for phosphorylated Ser 5 and 8WG16 RNAP were performed using anti-RNAP CTD4H8
(Covance) or Ms 8WG16 (Covance), respectively, as described previously8 with the
following modifications. Magnetic beads (Active Motif) were incubated with rabbit anti-
mouse antibodies (Jackson Immunoresearch; 10 μg per 50 μl of beads) for 1 h at 4 °C and
washed with sonication buffer. Chromatin (700 μg, determined by measuring absorbance of
alkaline-lysed, crosslinked chromatin) was immunoprecipitated (overnight at 4 °C) with 10
μl antibody and 50 μl of beads (with bridging antibody). Immunoprecipitated DNA of the
different ChIP experiments was analysed using real-time PCR4. Primer sequences are
available upon request.
Gene expression analysis by RT-qPCR
RNA was isolated using the RNeasy Kit (Qiagen), reverse transcribed using SuperScriptIII
as recommended by the manufacturer (Invitrogen) and analysed by real-time PCR using
Quantitect SYBR green PCR kit (Qiagen), as described previously4. Primer sequences are
available upon request.
Jarid2 KO ES targeting, genotyping and cell culture
Feeder-free adapted parental JM8 (wild-type) mouse ES cells are derived from the C57BL6/
N mouse strain38. Jarid2 mutant mouse embryonic stem (mES) cell lines were obtained
using targeted genetrapping approaches39. JM8 and Jarid2 heterozygous mutant mES cells
were generated by the Wellcome Trust Sanger Institute’s knockout mouse project (http://
www.komp.org) production center (W.C. Skarnes, et al., manuscript in preparation). The
Jarid2 heterozygous mutant ‘KO first’ allele contains a standard β-geo trapping cassette
targeted by replacement mutagenesis into the intron 1-2. Jarid2 homozygous mutant mES
cell lines were generated using an insertion type vector containing a hygromycin resistance
gene, an enhanced GFP marker, and a poly(A) sequence in a gene trapping cassette that
targets intron 2-3. Further details on the second allele targeting strategy will be published
elsewhere (C. Fisher and W.C. Skarnes, in preparation). Correct targeting of the first allele
was reconfirmed by genomic long-range PCR (LRPCR) using the gene-specific primer: 5′-
AGGTATTTTGTTCGCCGTGTGTTTC-3′ and the vector-specific primer: 5′-
GCCTCTTCGCTATTACGCCAGCTG-3′. Correct targeting of the second allele was
reconfirmed by LRPCR using the gene-specific primer: 5′-
TCTTTCTGTGCCTTGTTCTGACCTG-3′ and the vector-specific primer: 5′-
GCAGCTATTTACCCGCAGGA-3′. PCR reactions were performed using the ‘Expand
Long Template’ PCR system (Roche).
Alkaline phosphatase activity was determined using alkaline phosphatase kit (Sigma). Cell-
cycle profile was analysed by staining ice-cold ethanol fixed cells with propidium iodide
followed by analysis with FACSCalibur (Beckton Dickinson). Oct4 immunofluorescence
analysis was carried out using Ms anti-Oct3/4 (BD bioscience) antibody.
ES cell culture and differentiation
Bry201 ES cells (V. Kouskoff, University of Manchester, UK) were maintained and
differentiated as described elsewhere27. Differentiation of JM8 and Jarid2-deficient ES cells
was induced by LIF withdrawal in monolayer cultures (5 × 103 cells per cm2, plated on
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gelatinized flasks in ES medium). Monolayer differentiation towards neural lineage in
serum-free neural differentiation medium N2B27 (Stem Cell Sciences) was carried out as
described previously elsewhere34. Monolayer differentiation to mesoderm was carried out as
described35. For embryoid body differentiation, 7 × 106 cells were plated in non-adherent
plates in ES cell medium without LIF. To obtain mesoderm-enriched embryoid bodies, cells
were differentiated as described elsewhere27. At 3.75 days of differentiation EBs were
stained for FACS analysis using PE-Flk1 antibody (BD Bioscience,).
Bisulphite genomic sequencing
Bisulphite genomic sequencing was carried out as described previously40 with
oligonucleotides detailed in Supplementary Information, Table S1.
Statistical analysis
Statistical significance of PCR and ChIP-chip experiments was determined by applying a
one-tailed Student’s t-test to raw enrichment values and Chi-squared test, respectively.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Jarid2 selectively associates with PRC2 proteins in mouse ES cells and localizes to PRC2-
bound promoters. (a, b) Mass spectrometric analysis of Flag-immunoprecipitates from
2×Flag–Eed- or 2×Flag–Jarid2-expressing ES cells. Silver staining of 2×Flag–Eed
immunoprecipitation (a) and Coomassie staining of 2×Flag–Jarid2 immunoprecipitation (b)
is shown. Insets show bands present only in the Flag-transfected samples that correspond to
PRC2 subunits, assigned according to molecular size. Unique peptides detected in two
independent mass spectrometric experiments and their mascot scores are indicated. (c)
Western blot analysis of nuclear extracts of E14 ES cells immunoprecipitated with a mouse
anti-Eed (in the presence or absence of ethidium bromide; EtBr) and blotted with antiserum
to Jarid2, Eed, Ezh2 and Suz12. Mouse immunoglobulin-G (IgG) was used as a negative
control. Anti-Eed detected Eed isoforms 1, 3 and 4 as indicated (i1, i3 and i4). (d) Western
blot analysis using antibodies described in (c) of anti-Flag immunoprecipitated material
from parental (E14) and 2×Flag–Jarid2-transfected ES cells. (e) Overlay of data from
2×Flag–Jarid2 ChIP-chip genomic tiling array (grey, two replicates; as designed in ref. 19)
with published ChIP-chip promoter array analysis of polycomb group proteins (green) and
H3K27 trimethylation (blue)2. (f) Comparison of 2×Flag–Jarid2 (black) with ChIP-chip data
for H3K4me2 (K4+) and H3K27me3 (K27+; ref. 20) shows significant (P = 2.31×10−62,
chi-squared test) preference of Jarid2 for bivalent (K4+K27+) promoters.
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Figure 2.
Jarid2-null ES cells express pluripotency-associated factors and do not show global de-
repression of PRC2-target genes. (a) Western blot, using anti-Jarid2 and anti-Oct4
antibodies, of whole cell extracts of wild-type (JM8+/+) ES cells, a Jarid2 heterozygous
(A08+/−) line and two Jarid2 knockout cell lines (E4−/− and E8−/−). Lamin was used as a
loading control. Uncropped versions of the western blots are shown in Supplementary
Information, Figure S7. (b) Percentage of alkaline phosphatase-positive colonies showing a
compact, flat or spread morphology (mean ± s.d.). (c) Growth curve of JM8 (black line),
A08 (grey line), E4 (dashed line) and E8 (dashed line) ES cells over 4 days. (d) Percentage
of methylene blue-stained colonies (mean ± s.d.) detected 8 days after plating 100 cells per
well; representative images of methylene blue-stained colonies plated at 500 cells per well.
(e) Expression of PRC2-regulated genes in Jarid2-deficient cells (A08; grey, E4 and E8;
white) relative to wild-type control (JM8). Analysis of an Eed deficient ES cell line (clone
B1.3), in which PRC2 genes are de-repressed (blue), was included as a control. Mean ± s.d.
of three experiments is shown.
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Figure 3.
Jarid2 is required to recruit PRC2 to target genes in ES cells. (a, b) Binding of Ezh2 and
Suz12 to the promoter regions of genes, or across the Nkx2-2 locus, was assessed by ChIP.
Results show mean ± s.d. of three experiments where values are expressed relative to input.
Asterisks indicate statistical significant differences between JM8 wild-type and Jarid2
knockout cells (p < 0.05; Student’s t-test). (c, d) The abundance of modified histones was
assessed by ChIP using specific antibodies. Results show mean of two experiments and
values are expressed relative to H3 abundance. In (b) and (d) the abundance (mean) along
Nkx2-2, using primer pairs detailed in Supplementary Information, Figure S3, is plotted as a
function of distance to TSS (error bars are shown in Supplementary Information, Fig. S3).
Experiments were performed using wild-type (JM8, black), heterozygous (A08, grey) and
Jarid2-knockout ES cells (E4, E8, white bars or E4; red and E8; blue lines). A scheme of the
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Nkx2-2 locus displaying TSS (arrow) and three exons (black boxes) is shown in b. Ccnd1, a
putative Jarid2 target gene in cardiac myocytes29, and Oct4, Hprt and Myf5 were included
as controls.
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Figure 4.
Efficient recruitment of PRC1 and Ser5-phosphorylated RNAP to target genes in ES cells
requires Jarid2. (a) Ring1B and Mel18 binding at gene promoter regions (left panel), or
across the Nkx2-2 locus (right panel), was assessed by ChIP. Values and error bars are
shown in Supplementary Information, Figure S3, and the distance from the Nkx2-2 TSS is
indicated. (b) RNAP binding (Ser 5 phosphorylated or detected by 8WG16) was assessed by
ChIP. Right panel shows a schematic representation of the Nkx2-2 locus where the TSS, a
conserved region at −2.5 kb (light grey box), the coding region (8.7 kb containing three
exons, black boxes), untranslated regions (light grey boxes) and the position of primer pairs
are indicated. Results show mean ± s.d. of three experiments, where values are expressed
relative to input chromatin. Experiments were performed using wild-type (JM8, black),
heterozygous (A08, grey) and Jarid2-knockout ES cells (E4, E8, white bars or E4; red and
E8; blue lines). Hprt, Oct4 and Ccnd1 (active genes), and Gata1 and Myf5 (silent genes)
provide controls. Asterisks indicate statistical significant differences between JM8 wild-type
and Jarid2 knockout cells (P < 0.05; Student’s t-test).
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Figure 5.
Jarid2 is required for successful ES cell differentiation. Brightfield images of parental
(JM8+/+), heterozygous (A08+/−) and Jarid2-null (E8−/−) ES cells induced by (a) withdrawal
of LIF (upper panel, day 9), culture in neural-inducing N2B27 media34 (lower panel, day 5)
and (b) culture on Collagen IV-coated plates under mesoderm-inducing conditions35 (upper
panel, day 4). Flk1-expressing hemangioblasts were induced from embryoid bodies using
standard approaches27 and quantified by FACS (lower panel, day 3.75) where bar shows
gates used to identify Flk1+ cells. (c) Upper panel shows brightfield images where the
absence of Jarid2 results in fewer and smaller embryoid bodies induced upon LIF
withdrawal, compared with wild-type (day 5). Time course analysis of Oct4, Nanog and
Nestin expression in embryoid bodies by western blot (lower panel). (d) Kinetics of gene
expression during embryoid body formation (relative to undifferentiated ES cell controls).
Values for parental (black) and Jarid2-null (E8, white) ES cells are shown. Scale bars, 100
μm.
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